India's Gland Pharma to produce, supply up to 252 million Sputnik V vaccine doses
A nurse prepares Russia's "Sputnik-V" vaccine for inoculation in a post-registration trials stage at a clinic in Moscow. Photo: Reuters
India's Gland Pharma Ltd said on Tuesday it has entered into an agreement with the Russian Direct Investment Fund to produce and supply up to 252 million doses of the Sputnik V Covid-19 vaccine.
Keep updated, follow The Business Standard's Google news channel
